Abstract
Venous thromboembolism (VTE) is a common unrecognized and underestimated preventable condition; there are no data estimating the prevalence of VTE risk factors among the Iraqi patients or information’s about the Iraqi physician’s practice for prophylaxis.
Objective Assessing the prevalence of high-risk medical and surgical patients for developing VTE and to evaluate the utilization of appropriate prophylaxis in Iraq.
Methods A prospective study conducted in eligible medical and surgical wards in ALYARMOUK teaching hospital in Baghdad-Iraq, we used Padua score and Caprini score as risk assessment models for medical and surgical patients, respectively, while the prophylaxis approaches were assessed according to the American College of Chest
Physicians (ACCP) eighth edition.
Results We enrolled 574 patients in this study (296 medical; 278 surgical) from April to June 2016, two hundred sixty-seven patients (46.5%) were at risk of VTE; 115 (38.9%) medical patients and 152 (54.7%) surgical patients. Among them, only 9 (7.8%) medical patients and 4 (2.6%) surgical patients received some form of prophylaxis. Only 25% of the prescribed prophylaxis was ordered according to the ACCP recommendations. Mechanical prophylaxis has never been ordered.
Conclusion The prevalence of VTE risk is high in both medical and surgical patients with clear underutilization of prophylaxis for at-risk Iraqi hospitalized patients. The is a great need for implementing an educational program to improve both the quantity and quality of prophylaxis.
Keywords
Full Text:
References
Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756–764.
White R. The Epidemiology of venous thromboembolism. Circulation. 2003;107:I4–8.
Heit JA, Melton LJ, Lohse CM, Petterson TM, Silverstein MD, Mohr DN, et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc.2001;76:1102–1110.
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism. American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133:381S–453S.
Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874–879.
Turpie AG. Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial. Am J Cardiol. 2000;86:48M–52M.
Alsayegh F, Kamaliddin H, Sheshah E, Bukhamseen N, Alkhuwaitir T, Elhoufi A. Assessment of venous thromboembolism risk and adequacy of prophylaxis in selected acute care medical centres in Arabian gulf states: results from the ENDORSE Study. Med Princ Pract. 2012;21:522–528.
Lutz L, Haas S, Hach-Wunderle V, et al. Venous thromboembolism in internal medicine: risk assessment and pharmaceutical prophylaxis: publication for the specialist forum. Med Welt.2002;53:231–234.
Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251:344–350.
Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism, the Padua Prediction Score: J Thromb Haemost. 2010;8:2450–2457.
Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Endorse Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (Endorse study): a multinational cross-sectional study. Lancet. 2008;371:387–394.
Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;212: 105-112.
Pannucci CJ, Bailey SH, Dreszer G, Fisher C, Zumsteg JW, Jaber RM, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2010;51:788–789.
Hostler D, Marx E, Moores LK, Petteys SK, Hostler JM, Mitchell JD, et al. Validation of the International Medical Prevention Registry on venous thromboembolism bleeding risk score. Chest.
;149:372–379.
Stinnett J, Pendleton R, Skordos L, Wheeler M, Rodgers GM. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.Am J Hematol. 2005;78:167–172.
Goubran HA, Sholkamy S, El-Haddad A, Mahmoud A, Rizkallah MA, Sobhy G. Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt. Thromb J. 2012;10:20.
Refbacks
- There are currently no refbacks.
Copyright (c) 2017 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.